扶桑薬品工業(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2014/06/13 | 日証協 | 87,394株 | +1.16% | 0株 | -100% | 179,177株 | +2.28% | 6,100株 | +510% |
| 2014/06/06 | 日証協 | 86,394株 | -3.36% | 3,000株 | 0% | 175,177株 | -7.4% | 1,000株 | -50% |
| 2014/05/30 | 日証協 | 89,394株 | -2.19% | 3,000株 | -66.67% | 189,177株 | +7.38% | 2,000株 | -88.24% |
| 2014/05/23 | 日証協 | 91,394株 | +3.39% | 9,000株 | +273.29% | 176,177株 | +0.57% | 17,000株 | -54.46% |
| 2014/05/16 | 日証協 | 88,394株 | +0.47% | 2,411株 | +141.1% | 175,177株 | +18.49% | 37,331株 | +366.64% |
| 2014/05/09 | 日証協 | 87,983株 | 0% | 1,000株 | -96.75% | 147,846株 | -3.9% | 8,000株 | +700% |
| 2014/05/02 | 日証協 | 87,983株 | 0% | 30,758株 | 0% | 153,846株 | -8.34% | 1,000株 | -66.67% |
| 2014/04/25 | 日証協 | 87,983株 | 0% | 0株 | -100% | 167,846株 | +4.35% | 3,000株 | -57.14% |
| 2014/04/18 | 日証協 | 87,983株 | -0.46% | 3,589株 | -10.28% | 160,846株 | -7.7% | 7,000株 | -89.71% |
| 2014/04/11 | 日証協 | 88,394株 | -5.77% | 4,000株 | +873.24% | 174,257株 | -3.86% | 68,000株 | +116.42% |
| 2014/04/04 | 日証協 | 93,805株 | -1.67% | 411株 | 0% | 181,258株 | +23.44% | 31,421株 | +14.6% |
| 2014/03/28 | 日証協 | 95,394株 | +33.62% | 0株 | 0% | 146,837株 | +31.3% | 27,417株 | +61.28% |
| 2014/03/20 | 日証協 | 71,394株 | -14.39% | 0株 | -100% | 111,837株 | -8.99% | 17,000株 | +54.53% |
| 2014/03/14 | 日証協 | 83,394株 | -1.18% | 1,000株 | -50% | 122,886株 | +5.12% | 11,001株 | -42.1% |
| 2014/03/07 | 日証協 | 84,394株 | -4.53% | 2,000株 | -71.43% | 116,896株 | +1.74% | 19,000株 | -34.49% |
| 2014/02/28 | 日証協 | 88,394株 | -4.33% | 7,000株 | 0% | 114,896株 | +8.5% | 29,001株 | 0% |
| 2014/02/21 | 日証協 | 92,394株 | -23.26% | 0株 | -100% | 105,896株 | -20.91% | 29,000株 | +383.33% |
| 2014/02/14 | 日証協 | 120,394株 | +18.74% | 18,000株 | +38.46% | 133,897株 | +10.75% | 6,000株 | -70% |
| 2014/02/07 | 日証協 | 101,394株 | -11.36% | 13,000株 | +550% | 120,897株 | -0.82% | 20,000株 | +53.82% |
※株式分割は考慮していませんのでご注意ください。